Publicacions en col·laboració amb investigadors/es de Universidad de Antioquia (9)

2023

  1. Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

    Pathogens, Vol. 12, Núm. 7

2018

  1. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies

    European Journal of Medicinal Chemistry, Vol. 158, pp. 68-81

  2. Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery

    European Journal of Medicinal Chemistry, Vol. 152, pp. 489-514

2016

  1. Exploring the scope of new arylamino alcohol derivatives: Synthesis, antimalarial evaluation, toxicological studies, and target exploration

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 6, Núm. 3, pp. 184-198

2014

  1. Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents

    Molecules, Vol. 19, Núm. 2, pp. 2166-2180

2013

  1. New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities

    Molecules, Vol. 18, Núm. 4, pp. 4718-4727

2012

  1. Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4- phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives

    Molecules, Vol. 17, Núm. 8, pp. 9451-9461

2011

  1. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships

    Experimental Parasitology, Vol. 128, Núm. 2, pp. 97-103

  2. New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 15, pp. 4498-4502